ROSUVASTATINE BIOGARAN 5 mg, film-coated tablet 30 tablets, CIP 3400930189214
Active ingredients: Rosuvastatin, Rosuvastatin zinc
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930189214orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROSUVASTATINE BIOGARAN 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec sécurité enfant
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 7 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65672729CIP73018921CIP133400930189214Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROSUVASTATINE ZINCIQUEcomprimé | — | SA |
| ROSUVASTATINEcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.